sglt2 inhibitors vs glp-1 Recommendations for SGLT2i versus RA on the basis of kidney 🚨 Avoid These Common Mistakes

Conclusion Both Contrave and Wegovy are effective prescription options for weight management

Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management

The proportion of patients achieving NASH resolution in the absence of fibrosis progression was 40%, 36%, and 59% for the 0.1, 0.2, and 0.4 mg semaglutide arms, respectively, whereas the corresponding rate in the placebo arm was 17% ( Notably, based on the results from part 1 of the ESSENCE trial, on 15 August 2025, the FDA approved semaglutide 2.4 mg for the treatment of adults with MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)

In addition to these serious side effects, Contrave may also cause seizures, liver problems, and visual problems

Our comprehensive approach to weight loss comes with support from medical providers who understand the nuance of weight gain and weight loss